Effect of cannabis on oxaliplatin-induced peripheral neuropathy among oncology patients: a retrospective analysis
Background: Chemotherapy-induced peripheral neuropathy (CIPN) is a common and dosage-limited oxaliplatin-related toxicity. To date, there are no successful interventions for CIPN prevention or treatment. A therapeutic role for cannabis in diabetic and HIV-related peripheral neuropathy and a protecti...
Main Authors: | Barliz Waissengrin, Dan Mirelman, Sharon Pelles, Felix Bukstein, Deborah T. Blumenthal, Ido Wolf, Ravit Geva |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2021-02-01
|
Series: | Therapeutic Advances in Medical Oncology |
Online Access: | https://doi.org/10.1177/1758835921990203 |
Similar Items
-
Management of Oxaliplatin-Induced Peripheral Sensory Neuropathy
by: Guido Cavaletti, et al.
Published: (2020-05-01) -
Metformin protects from oxaliplatin induced peripheral neuropathy in rats
by: N.W. Martinez, et al.
Published: (2020-08-01) -
Acute Peripheral Motor Neuropathy Induced by Oxaliplatin-Correlated Hypokalaemia
by: Riccardo Giampieri, et al.
Published: (2019-12-01) -
Analgesic Effect of Melittin on Oxaliplatin-Induced Peripheral Neuropathy in Rats
by: Seunghwan Choi, et al.
Published: (2019-07-01) -
Impact of Dose, Sex, and Strain on Oxaliplatin-Induced Peripheral Neuropathy in Mice
by: Urszula O. Warncke, et al.
Published: (2021-07-01)